Estimating health utilities and quality adjusted life years in seasonal affective disorder research

Journal of Affective Disorders

Volumn 100, Issue 1-3, 2007, Pages 83-89

  Freed, Michael C ^a   Rohan, Kelly J ^b   Yates, Brian T ^a  

^a AMERICAN UNIVERSITY   (United States)

^b Uniformed Services University of the Health Sciences and the Walter Reed National Military Medical Center   (United States)

Author keywords

Cost effectiveness; Depression; Health utility; Quality adjusted life year; Seasonal affective disorder

Indexed keywords

ARTICLE; CLINICAL ARTICLE; COGNITIVE THERAPY; CONTROLLED STUDY; DATA ANALYSIS; DISEASE SEVERITY; HEALTH CARE UTILIZATION; HUMAN; OUTCOME ASSESSMENT; PHOTOTHERAPY; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; QUALITY OF LIFE; RECURRENT DISEASE; REMISSION; SEASONAL AFFECTIVE DISORDER; SPRING; TIME; UNITED STATES;

COGNITIVE THERAPY; COSTS AND COST ANALYSIS; FOLLOW-UP STUDIES; HUMANS; MENTAL HEALTH SERVICES; PHOTOTHERAPY; PILOT PROJECTS; QUALITY OF LIFE; REMISSION INDUCTION; SEASONAL AFFECTIVE DISORDER; TIME FACTORS;

EID: 34249297340     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jad.2006.09.038     Document Type: Article

References (26)

1. American Psychiatric Association (APA), 2000 (2000), Quick Reference to the Diagnostic Criteria from DSM-IV-TR. Author:, Washington, DC
2. Barrett B., Byford S., and Knapp M. Evidence of cost-effective treatments for depression: a systematic review. J. Affect. Disord. 84 1 (2005) 1-13
3. Beck A.T., Steer R.A., and Brown G.K. Beck Depression Inventory®-Second Edition Manual (1996), The Psychological Corporation, Harcourt, Brace and Co, United States
4. Birtwistle J., and Martin N. Seasonal affective disorder: its recognition and treatment. Br. J. Nurs. 8 15 (1999) 1004-1009
5. Drummond M.F., O'Brien B., Stoddart G.L., and Torrance G.W. Methods for the Economic Evaluation of Health Care Programmes. 2nd ed. (1997), Oxford University Press, Oxford
6. Gold M.R., Siegel J.E., Russell L.B., and Weinstein M.C. Cost-Effectiveness in Health and Medicine (1996), Oxford University Press, New York
7. Hatziandreu E., Brown R.E., Revicki D.A., Turner R., Martindale J., Levine S., and Siegel J.E. Cost utility of maintenance treatment of recurrent depression with sertraline versus episodic treatment with dothiepin. Pharmacoeconomics 5 (1994) 249-268
8. Hlatk M. Patient preferences and clinical guidelines. JAMA 273 (1995) 1219-1220
9. Katon W.J., Schoenbaum M., Fan M., Callahan C.M., Williams J., Hunkeler E., et al. Cost-effectiveness of improving primary care treatment of late-life depression. Arch. Gen. Psychiatry 62 (2005) 1313-1320
10. Lave J.R., Frank R.G., Schulberg H.C., and Kamlet M.S. Cost-effectiveness of treatments for major depression in primary care practice. Arch. Gen. Psychiatry 55 (1998) 645-651
11. Mehta C., and Patel N. StatXact 4 for Windows User Manual (2000), CYTEL Software Corp., MA
12. Mersch P.P.A., Middendorp H.M., Bouhuys A.L., Beersma D.G.M., and van den Hoofdakker R.H. Seasonal affective disorder and latitude: a review of the literature. J. Affect. Disord. 53 1 (1999) 35-48
13. Montgomery A.A., and Fahey T. How do patients' treatment preferences compare with those of clinicians?. Qual. Saf. Health Care 10 (2001) i39-i43
14. O'Hagan A., and Luce B.R. A Primer on Bayesian Statistics in Health Economic and Outcomes Research (2003), MEDTAP International Inc., Bethesda, MD
15. Pyne J.M., Sieber W.J., David K., Kaplan R.M., Rapaport M.H., and Williams D.K. Use of the quality of well-being self-administered version (QWB-SA) in assessing health-related quality of life in depressed patients. J. Affect. Disord. 76 (2003) 237-247
16. Revicki D.A., and Wood M. Patient-assigned health state utilities for depression-related outcomes: differences by depression severity and antidepressant medications. J. Affect. Disord. 48 (1998) 25-36
17. Revicki D.A., Brown R.E., and Palmer W. Modeling the cost effectiveness of antidepressant treatment in primary care. Pharmacoeconomics 8 (1995) 524-540
18. Revicki D.A., Brown R.E., and Keller M.B. Cost-effectiveness of newer antidepressants compared with tricyclic antidepressants in managed care settings. J. Clin. Psychiatry 58 (1997) 47-58
19. Rohan K.J., Lindsey K.T., Roecklein K.A., and Lacy T.J. Cognitive-behavioral therapy, light therapy, and their combination in treating seasonal affective disorder. J. Affect. Disord. 80 (2004) 273-283
20. Rosen L.N., Targum S.D., Terman M., Bryant M.J., Hoffman H., Kasper S.F., Hamovit J.R., Docherty J.P., Welch B., and Rosenthal N.E. Prevalence of seasonal affective disorder at four latitudes. Psychiatry Res. 31 (1990) 131-144
21. Sakamoto K., Nakadaira S., Kamo K., Kamo T., and Takahashi K. A longitudinal follow-up study of seasonal affective disorder. Am. J. Psychiatry 152 6 (1995) 862-868
22. Terman M., Terman J.S., Quitkin F., McGrath P., Stewart J., and Rafferty B. Light therapy for seasonal affective disorder: a review of efficacy. Neuropsychopharmacology 2 (1989) 1-22
23. Torrance G.W., and Feeny D. Utilities and quality-adjusted life years. Int. J. Technol. Assess Health Care 5 (1989) 559-575
24. Weinstein M.C., and Stason W.B. Foundations of cost-effectiveness analysis for health and medical practices. N. Engl. J. Med. 296 13 (1977) 716-721
25. Williams J.B., Link M.J., Rosenthal N.E., Amira L., and Terman M. Structured Interview Guide for the Hamilton Depression Rating Scale-Seasonal Affective Disorder Version (SIGH-SAD) (1992), New York State Psychiatric Institute, New York
26. Yates B. Toward the incorporation of costs, cost-effectiveness analysis, and cost-benefit analysis into clinical research. J. Consult. Clin. Psychol. 62 4 (1994) 729-736